Table 3

ORs for postendoscopy GI bleeding, thromboembolism and death in the warfarin group with reference to the DOAC group, adjusting for high-risk endoscopic procedures (n=10 092)

Postendoscopy GI bleedingPostendoscopy thromboembolismPostendoscopy death
OR (95% CI)p ValueOR (95% CI)p ValueOR (95% CI)p Value
Anticoagulants
 DOACsReferenceReferenceReference
 Warfarin1.22 (1.07 to 1.39)0.0031.16 (0.97 to 1.39)0.0991.15 (0.96 to 1.38)0.126
Endoscopic procedures
 PEGReferenceReferenceReference
 Upper GI haemostasis13.6 (9.93 to 18.5)<0.0010.98 (0.76 to 1.26)0.8710.68 (0.54 to 0.84)<0.001
 Lower GI EMR7.27 (5.21 to 10.1)<0.0010.59 (0.43 to 0.81)0.0010.06 (0.03 to 0.12)<0.001
 EST3.45 (2.39 to 5.00)<0.0010.86 (0.65 to 1.14)0.2850.18 (0.12 to 0.26)<0.001
 Lower GI haemostasis11.0 (7.70 to 15.8)<0.0010.98 (0.68 to 1.42)0.9200.43 (0.29 to 0.64)<0.001
 Upper GI ESD45.2 (32.4 to 62.7)<0.0010.72 (0.47 to 1.10)0.1260.08 (0.034 to 0.20)<0.001
 Lower GI polypectomy7.83 (5.21 to 11.8)<0.0010.51 (0.29 to 0.88)0.0160.02 (0.003 to 0.154)<0.001
 Lower GI ESD10.0 (6.29 to 16.0)<0.0010.64 (0.32 to 1.27)0.202NA*NA*
 EUS-FNA2.32 (1.08 to 4.98)0.0301.10 (0.63 to 1.93)0.7430.80 (0.48 to 1.33)0.383
 Upper GI EMR/polypectomy14.69 (8.93 to 24.2)<0.0010.44 (0.16 to 1.20)0.1090.06 (0.01 to 0.45)0.006
 Endoscopic balloon dilatation0.40 (0.06 to 2.95)0.3720.66 (0.29 to 1.52)0.3270.60 (0.30 to 1.18)0.137
 EVL17.62 (10.3 to 30.2)<0.0010.15 (0.02 to 1.08)0.0600.97 (0.50 to 1.88)0.924
 EIS10.87 (4.85 to 24.3)<0.0011.31 (0.47 to 3.68)0.6070.18 (0.02 to 1.32)0.092
  • *NA: no deaths occurred in association with any procedure.

  • DOACs, direct oral anticoagulants; EIS, endoscopic injection sclerotherapy; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; EST, endoscopic sphincterotomy; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration; EVL, endoscopic variceal ligation; PEG, percutaneous endoscopic gastrostomy.